Regulatory Blog

The global life sciences landscape is rapidly evolving with the integration of advanced artificial intelligence to accelerate drug discovery, genomics, and translational research . OpenAI has introduced a specialized model designed to address the complexity and scale of modern biomedical research workflows. The announcement Introducing GPT-Rosalind for life sciences research , published in April 2026 , presents a purpose-built AI model aimed at supporting scientific reasoning